Pubblicazioni

• 24.08.2017

  Dihydropyrimidine dehydrogenase pharmaco- genetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

• 18.07.2017

  Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution

• 16.06.2017

  Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report

• 15.06.2017

  Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene

• 23.05.2017

  Adenosquamous gallbladder carcinoma: multigene hotspot mutational profiling reveals a monoclonal origin of the two components

• 30.03.2017

  Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver

• 20.03.2017

  Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases

• 31.01.2017

  Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis

• 03.01.2017

  Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

• 02.01.2017

  Analysis of KRAS, NRAS, PIK3CA and BRAF mutational profile in poorly differentiated clusters (PDC) of KRAS mutated colon cancer